To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

August 11, 2022

Founder Dellann Speaks About The Last 20 Years At EBCI w/NW News Radio

Photo of founder Dellann and radio promo

Last month, our founder, Dellann, had an amazing discussion with host of Puget Sound Now, Bill Swartz to discuss a bit of EBCI' story. As 2022 is our 20th year of making a difference in the brain tumor community, please take a moment to listen to how far we've come since our beginning in 2002!

EBCI helps guide brain tumor patients and their caregivers through their treatment journey including connecting and referring them to specialists in cancer centers offering the latest innovations in treating brain tumors. To learn more about the services that EBCI provides and to connect with our President & CEO please click through to our website and fill out a Research Collaboration Inquiry Form.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram